A research team led by the University of California, Irvine has linked the mutation that causes Huntington's disease to developmental deficits in the brain's oligodendrocyte cells that are caused by changes in metabolism. ...
Dec 21, 2022
0
69
Glioblastoma, the most common cancerous brain tumor in adults, is an aggressive disease—patients survive an average of just 15 months once they are diagnosed. Despite more than two decades of research on the causes and ...
Sep 26, 2022
1
59
Over the past two years, scientists have studied the SARS-CoV-2 virus in great detail, laying the foundation for developing COVID-19 vaccines and antiviral treatments. Now, for the first time, scientists at the Department ...
Sep 8, 2022
5
130
Scientists at the Francis Crick Institute, UCL and the University of Edinburgh have uncovered how a build-up of harmful protein starts to happen within neurons in Parkinson's disease, ultimately causing nerve cell death. ...
Aug 30, 2022
0
133
Researchers at the University of Southampton have gained unprecedented new insight into the key properties of an antibody needed to fight off cancer.
Jul 8, 2022
0
62
Imbalances in brain chemistry are at the heart of many neurologic diseases. These same brain chemicals also play roles in gut health. So, scientists at Stanford have invented "NeuroString"—a soft implantable probe that ...
Jun 1, 2022
0
145
Imatinib, better known as Gleevec, was hailed as a "miracle" cancer drug when it entered the market in the early 2000s. Though it has been highly successful at treating early-stage chronic myeloid leukemia (CML)—a rare ...
Jun 1, 2022
0
150
Gene editing may be a potential treatment for anxiety and alcohol use disorder in adults who were exposed to binge drinking in their adolescence, according to the results of an animal study published in the journal Science ...
May 4, 2022
3
118
A wireless, biodegradable sensor could offer doctors a way to monitor changes in brain chemistry without requiring a second operation to remove the implant, according to an international team of researchers.
Mar 22, 2022
0
368
The United States recently secured 1.7 million doses of a compound that could help to treat COVID-19 patients. In preliminary studies, Molnupiravir reduced the transmission of the SARS-CoV-2 coronavirus. Researchers at the ...
Aug 16, 2021
0
1070
